Trinity Biotech (TRIB) Return on Invested Capital (2009 - 2024)

Trinity Biotech has disclosed Return on Invested Capital across 5 years of filings, most recently posting 0.03% for Q2 2024.

• Return on Invested Capital for Q2 2024 came in at 0.03%, up 3.0% year-over-year; the trailing twelve-month figure through Jun 2024 was 0.03% (up 3.0% YoY), and the FY2025 annual result was 0.0%, down 6.0% from the prior year.
• Return on Invested Capital came in at 0.03% for Q2 2024 at Trinity Biotech, down from 0.02% in the prior quarter.
• In the past five years, Return on Invested Capital ranged from a high of 0.02% in Q3 2022 to a low of 0.14% in Q1 2023.
• The 3-year median for Return on Invested Capital is 0.04% (2024), against an average of 0.05%.
• Across the five-year window, Return on Invested Capital slipped 3 bps in 2023 and gained 12 bps in 2024, its largest moves.
• Trinity Biotech's Return on Invested Capital stood at 0.06% in 2022, then jumped by 61 bps to 0.02% in 2023, then retreated by 17 bps to 0.03% in 2024.
• The last three Return on Invested Capital figures came in at 0.03% (Q2 2024), 0.02% (Q1 2024), and 0.02% (Q4 2023), per Business Quant data.